Results 181 to 190 of about 227,863 (293)

Circulating DPP3 limits efficacy of angiotensin II infusion in septic shock. [PDF]

Crit Care
van Lier D, Santos K, Hartmann O, Kox M, Pickkers P.   +4 more
europepmc   +1 more source

Disturbances of selected plasma proteins in Hyperdynamic Septic Shock [PDF]

, 1982
A Ledgerwood, AO Aasen, AO Aasen, CB Laurell, D Collen, DL Heene, DM Rangel, EA Friedmann, EF Gersmeyer, FW Putnam, H Fritz, H Graeff, H Schiessler, H. Fritz, HG Lasch, J Johnson, J. Witte, JW Alexander, K Havemann, K Hochstrasser, K Messmer, K Ohlsson, K. Hochstrasser, M Jochum, M Jochum, M. Jochum, MS Losowsky, N Freudenberg, P Skansberg, PJ Hamilton, PM Starkey, R Dielt, R Egbring, R Hafter, R. Scherer, RG Lerner, W Schramm, W Schramm, W. Schramm   +38 more
core   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

British Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse, Christophe Hommel, Nadine Petitpain, Philippe Kerschen   +3 more
wiley   +1 more source

Albumin Replacement Therapy in Septic Shock: A Randomized Clinical Trial.

JAMA Netw Open
Sakr Y, Nierhaus A, Schumacher U, Utzolino S, Jaschinski U, Petros S, Fichtner F, Eimer C, Putensen C, Tanev I, Kreienbühl L, Kluge S, Kousoulas L, Kuhn SO, Jarczak D, Quintel M, Bauer M, SepNet Critical Care Trials Group and Albumin Replacement Therapy in Septic Shock (ARISS) investigators.   +17 more
europepmc   +1 more source

Recurrent Septic Shock in Immunosuppressed Patients. [PDF]

Clin Case Rep
Fukushima S, Fujita K, Hagiya H.
europepmc   +1 more source

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source

Platelet proteome for predictive diagnosis and differentiation of sepsis and septic shock in pediatric patients. [PDF]

PeerJ
Cao Y, Chen K, Chen C, Qiu M, Chen F, Zhao L, Li F, Luo J, Tang WT, Wang Y, Su M.   +10 more
europepmc   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Acute hemodynamic tests to determine the status of macro-to-microcirculatory coupling during septic shock resuscitation. [PDF]

Crit Care
Hernández G, Ospina-Tascón GA, De Backer D, Teboul JL, Melo P, Morales S, Castro R, Kattan E.   +7 more
europepmc   +1 more source

Empiric antibiotics for sepsis [PDF]

, 2018
Buckman, Sara A, Mazuski, John E, Turnbull, Isaiah R   +2 more
core   +2 more sources